Literature DB >> 3742889

Anticardiolipin response in acute infections.

O Vaarala, T Palosuo, M Kleemola, K Aho.   

Abstract

Paired serum specimens from 149 patients with six different infections verified by a significant rise in the specific antibody level were tested for anticardiolipin antibodies using enzyme-linked immunosorbent assay. Significantly raised levels, at least in one immunoglobulin class, were detected in 32% of the cases, and significant changes in the level indicating an ongoing process, in 26%. Taken as a whole, the response involved the immunoglobulins IgG, IgM, and IgA, although in patients with mumps the significantly raised levels were virtually confined to the IgA class. The binding of syphilitic antibodies to solid-phase cardiolipin was readily inhibited by cardiolipin liposomes, whereas this pattern of reactivity was noted in only one of four nonsyphilitic sera. It was concluded that anticardiolipin antibodies occur very frequently in a wide variety of uncomplicated infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742889     DOI: 10.1016/0090-1229(86)90046-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  39 in total

1.  Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.

Authors:  B S Tzang; T Y Chen; T C Hsu; Y C Liu; G J Tsay
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  Correction for age of anticardiolipin antibodies cut-off points.

Authors:  E Rapizzi; A Ruffatti; M Tonello; A Piccoli; A Calligaro; P Sfriso; S Todesco
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura.

Authors:  Y H Yang; M T Huang; S C Lin; Y T Lin; M J Tsai; B L Chiang
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 4.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

5.  Antiphospholipid antibodies and Mycoplasma pneumoniae infection.

Authors:  N Snowden; P B Wilson; M Longson; R S Pumphrey
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

6.  Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Authors:  H J Out; M van Vliet; P G de Groot; R H Derksen
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

7.  False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion.

Authors:  S Cowchock; J Fort; S Munoz; R Norberg; W Maddrey
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 8.  The antiphospholipid syndrome. Diagnosis, management, and pathogenesis.

Authors:  E N Harris
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

9.  Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients.

Authors:  Roozbeh Jamshid; Serati Ali Reza; Ghaderi Abbas; Afshariani Raha
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

10.  High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria.

Authors:  C A Facer; G Agiostratidou
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.